The Radiant Light: Efficacy and Safety of Oveporexton (TAK-861), an Oral Orexin Receptor 2 Agonist for the Treatment of Narcolepsy Type 1

Sleep Medicine 2026

View at publisher
Authors: Y. Dauvilliers, J. Antczak, E. Buntinx, R. del Rio Víllegas, S.-C. Hong, S. Sivam, S. Zhan, E. Koundourakis, R. Neuwirth, T. Olsson, S. Sheikh, P. von Rosenstiel
+3 more B. Yao, A. Cai, G. Plazzi
DOI: 10.1016/j.sleep.2025.107567
Cited by: 2

Fields of Study & Subjects

Sleep and Wakefulness Research Sleep and Work-Related Fatigue Restless Legs Syndrome Research

Publication details

Journal / source
Sleep Medicine
Publisher
Elsevier BV
Volume
138
Pages
107567–107567
Publication date
29 January 2026
Language
EN